Post-discharge oral nutritional supplements with dietary advice in patients at nutritional risk after surgery for gastric cancer: A randomized controlled trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000029708

Enrollment

Unknown

Registered

2020-02-09

Start date

2017-01-01

Completion date

Unknown

Last updated

2020-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

ONS group:patients received dietary advice and oral intake of Nutren Optimum (Nestle Health Science, Switzerland) at a dosage of 500 mL daily for 3 months after discharge as a supplement to regular me

Control group:patients received dietary advice alone, which was identical to those for ONS group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients were enrolled if they discharged after surgery for gastric cancer and had nutritional risk score at 3; 2. greater based on the nutritional risk screening 2002 (NRS-2002) tool.

Exclusion criteria

Exclusion criteria: Participants unable to take food orally, already on nutritional support therapy, pregnant, or under age of 18 years.

Design outcomes

Primary

Measure	Time frame
Nutritional outcomes;The rate of low skeletal muscle index;	—

Secondary

Measure	Time frame
Chemotherapy tolerance;90-day readmission rate;Quality of life;	—

Countries

China

Contacts

Public ContactGuohao Wu

Department of General Surgery/Shanghai Clinical Nutrition Research Center, Zhongshan Hospital, Fudan University

wuguohaozs@163.com+86 13901666088

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026